Our group company, ARCALIS, Inc. has entered into a Memorandum of Understanding for comprehensive collaboration with the Fukushima Medical University and the Fukushima Translational Research Foundation to advance research, development, and manufacturing of mRNA pharmaceuticals and vaccines.

For more information, please see the ARCALIS press release.